المؤلفون: Yan S; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zhu X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Xiao Y; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 09; Vol. 15, pp. 1428101. Date of Electronic Publication: 2024 Jul 09 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Graft vs Host Disease*/etiology, Humans ; Recurrence ; Treatment Outcome ; Transplantation Conditioning/methods ; Hematologic Neoplasms/therapy ; Hematologic Neoplasms/immunology

المؤلفون: Nagayama T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.; Division of Cell Transplantation and Transfusion, Jichi Medical University Hospital, Tochigi, Japan., Fujiwara SI; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.; Division of Cell Transplantation and Transfusion, Jichi Medical University Hospital, Tochigi, Japan., Tominaga R; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Yokoyama D; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Noguchi A; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Furuki S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Oyama T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Koyama S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Murahashi R; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Nakashima H; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Ikeda T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Hyodo K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Kawaguchi SI; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Toda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Umino K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Minakata D; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Morita K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Ashizawa M; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Yamamoto C; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Hatano K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Sato K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Ohmine K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan., Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 Sep; Vol. 65 (9), pp. 1350-1356. Date of Electronic Publication: 2024 May 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Transplantation, Homologous* , CD4-CD8 Ratio* , Hematologic Neoplasms*/therapy , Hematologic Neoplasms*/mortality , Hematologic Neoplasms*/diagnosis, Humans ; Male ; Adult ; Female ; Middle Aged ; Prognosis ; Young Adult ; Adolescent ; Retrospective Studies ; Aged ; Graft vs Host Disease/etiology ; Graft vs Host Disease/diagnosis ; Treatment Outcome ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism

المؤلفون: Zhang J; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.; Reproductive Medical Center, Peking University People's Hospital, Beijing, China., Li X; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China., Liang R; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.; Reproductive Medical Center, Peking University People's Hospital, Beijing, China., Duan S; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.; Reproductive Medical Center, Peking University People's Hospital, Beijing, China., Yang X; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China., Hou Y; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.; Reproductive Medical Center, Peking University People's Hospital, Beijing, China., Tian L; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.; Reproductive Medical Center, Peking University People's Hospital, Beijing, China.

المصدر: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Aug 26; Vol. 15, pp. 1367241. Date of Electronic Publication: 2024 Aug 26 (Print Publication: 2024).

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE

مواضيع طبية MeSH: Cryopreservation* , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Ovary*/pathology , Fertility Preservation*/methods, Humans ; Female ; Young Adult ; Graft Rejection/etiology ; Transplantation, Homologous ; Anemia, Aplastic/therapy ; Adult ; Ovarian Reserve

المؤلفون: Zhang L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Li J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Liang W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Zhang X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Chen S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Shi Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Hao M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Zhao X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Gong M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Wei J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., He Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Jiang E; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Han M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Zhang F; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China., Feng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.; Tianjin Institutes of Health Science, Tianjin, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Aug 16; Vol. 15, pp. 1425076. Date of Electronic Publication: 2024 Aug 16 (Print Publication: 2024).

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Aplastic*/therapy , Anemia, Aplastic*/mortality , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Graft vs Host Disease*/etiology , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/administration & dosage , Recurrence*, Humans ; Male ; Female ; Adolescent ; Adult ; Child ; Young Adult ; Child, Preschool ; Middle Aged ; Treatment Outcome ; Antilymphocyte Serum/therapeutic use ; Antilymphocyte Serum/administration & dosage ; Transplantation, Homologous ; Cyclophosphamide/therapeutic use ; Cyclophosphamide/administration & dosage ; Immunosuppression Therapy/methods ; Retrospective Studies ; Cyclosporine/therapeutic use ; Cyclosporine/administration & dosage

المؤلفون: Barbarito G; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Hiroshima L; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Oppizzi L; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Saini G; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Kristovich K; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Klein O; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Hosszu K; MSK Kids, Transplantation and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York; Immune Discovery and Monitoring Service, Department of Pediatrics and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Boehlke K; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Gupta A; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Mcavoy D; MSK Kids, Transplantation and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York; Immune Discovery and Monitoring Service, Department of Pediatrics and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Shyr D; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California., Boelens JJ; MSK Kids, Transplantation and Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York; Immune Discovery and Monitoring Service, Department of Pediatrics and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Bertaina A; Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California. Electronic address: aliceb1@stanford.edu.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Aug; Vol. 30 (8), pp. 810.e1-810.e16. Date of Electronic Publication: 2024 May 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/prevention & control , Antilymphocyte Serum*/therapeutic use , Antilymphocyte Serum*/administration & dosage , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , T-Lymphocytes*/immunology , T-Lymphocytes*/drug effects, Humans ; Child ; Male ; Female ; Adolescent ; Child, Preschool ; Acute Disease ; Infant ; Receptors, Antigen, T-Cell, alpha-beta/metabolism

المؤلفون: Ben Abdeljelil N; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Ben Yaiche I; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Ouerghi R; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Torjemane L; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Belloumi D; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Turki I; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Mekni S; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Kanoun RY; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Ben Othman T; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia., Ladeb S; Centre National de Greffe de Moelle Osseuse, Université de Tunis El Manar Tunis, Tunis, Tunisia.

المصدر: Expert review of hematology [Expert Rev Hematol] 2024 Aug; Vol. 17 (8), pp. 527-538. Date of Electronic Publication: 2024 Jul 23.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Aplastic*/therapy , Anemia, Aplastic*/mortality , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Antilymphocyte Serum*/therapeutic use , Cyclophosphamide*/therapeutic use , Transplantation Conditioning*/methods , Vidarabine*/analogs & derivatives , Vidarabine*/therapeutic use , Vidarabine*/administration & dosage , Siblings*, Humans ; Male ; Female ; Animals ; Adolescent ; Retrospective Studies ; Adult ; Horses ; Rabbits ; Child ; Transplantation, Homologous ; Tissue Donors ; Young Adult ; Graft vs Host Disease/etiology ; Graft vs Host Disease/prevention & control ; Child, Preschool ; Middle Aged

المؤلفون: Richardson T; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Scheid C; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Herling M; Department of Hematology, Cellular Therapy, and Hemostaseology, University Hospital Leipzig, Leipzig, Germany., Frenzel LP; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Herling C; Department of Hematology, Cellular Therapy, and Hemostaseology, University Hospital Leipzig, Leipzig, Germany., Aguilar MRC; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Theurich S; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany., Hallek M; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany., Holtick U; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.

المصدر: European journal of haematology [Eur J Haematol] 2024 Aug; Vol. 113 (2), pp. 163-171. Date of Electronic Publication: 2024 Apr 14.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control , Everolimus*/administration & dosage , Everolimus*/therapeutic use , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage , Multiple Myeloma*/therapy , Multiple Myeloma*/mortality , Multiple Myeloma*/diagnosis , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Transplantation Conditioning*/methods, Humans ; Female ; Middle Aged ; Male ; Adult ; Aged ; Recurrence ; Lymphoma/therapy ; Lymphoma/mortality ; Lymphoma/diagnosis ; Treatment Outcome ; Immunosuppressive Agents/therapeutic use ; Immunosuppressive Agents/administration & dosage ; Transplantation, Homologous

المؤلفون: Lee BJ; Department of Pharmacy, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, California., Vittayawacharin P; Division of Hematology-Oncology, Department of Medicine, Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California; Division of Hematology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Griffin SP; Department of Pharmacy, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, California., Doh J; Department of Pharmacy, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California, USA; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, California., Nam HH; Division of Infectious Diseases, Department of Medicine, University of California Irvine Health, Orange, California., Jeyakumar D; Division of Hematology-Oncology, Department of Medicine, Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California., Blodget E; Division of Infectious Diseases, Department of Medicine, University of California Irvine Health, Orange, California., Kongtim P; Division of Hematology-Oncology, Department of Medicine, Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California., Ciurea SO; Division of Hematology-Oncology, Department of Medicine, Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Chao Family Comprehensive Cancer Center, University of California Irvine Health, Orange, California. Electronic address: sciurea@hs.uci.edu.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Aug; Vol. 30 (8), pp. 816.e1-816.e10. Date of Electronic Publication: 2024 May 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/mortality , COVID-19*/immunology , COVID-19*/therapy , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/mortality , Immune Reconstitution* , SARS-CoV-2*/immunology , Transplantation, Homologous*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Aged

المؤلفون: Zadik Y; Department of Oral Medicine, Faculty of Dental Medicine, The Hebrew University of Jerusalem, and Hadassah-University Medical Center, P.O.B. 12272, 9112002, Jerusalem, Israel. yehuda.zadik@mail.huji.ac.il.; Saligman Clinics, Faculty of Dental Medicine, The Hebrew University of Jerusalem, and Hadassah-University Medical Center, Jerusalem, Israel. yehuda.zadik@mail.huji.ac.il., Raber-Durlacher JE; Department of Oral Medicine, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and VU University, Amsterdam, The Netherlands.; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Epstein JB; Cedars-Sinai Health System, Los Angeles, CA, USA.; Dental Oncology Service, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Majorana A; Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, School of Pediatric Dentistry, University of Brescia, Brescia, Italy., Laheij A; Department of Oral Medicine, Academic Center for Dentistry Amsterdam (ACTA), University of Amsterdam and VU University, Amsterdam, The Netherlands.; Department of Oral and Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bardellini E; Department of Medical and Surgical Specialities, Radiological Sciences and Public Health, School of Pediatric Dentistry, University of Brescia, Brescia, Italy., Blijlevens N; Department of Hematology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands., Elad S; Oral Medicine, Eastman Institute for Oral Health, University of Rochester Medical Center, Rochester, NY, USA.

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jul 25; Vol. 32 (8), pp. 546. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article; Practice Guideline; Review

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/therapy , Graft vs Host Disease*/etiology , Mouth Diseases*/etiology , Mouth Diseases*/therapy , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods, Humans ; Chronic Disease ; Xerostomia/etiology ; Xerostomia/therapy

المؤلفون: Satirer Ö; Department of Paediatrics and Autoinflammation reference Center Tuebingen (arcT), Universitatsklinikum Tubingen, Tubingen, Baden-Württemberg, Germany., Henes JC; Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Oncology, Haematology, Immunology and Rheumatology), Universitatsklinikum Tubingen, Tubingen, Baden-Württemberg, Germany., Döring M; Pediatric Hematology &Oncology, University of Tübingen, Tubingen, Baden-Württemberg, Germany., Lesk T; Universitatsklinikum Tubingen, Tubingen, Baden-Württemberg, Germany., Benseler S; Rheumatology, Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada.; Children's Health Ireland, Dublin, Dublin, Ireland., Kuemmerle-Deschner JB; Department of Paediatrics and Autoinflammation reference Center Tuebingen (arcT), Universitatsklinikum Tubingen, Tubingen, Baden-Württemberg, Germany kuemmerle.deschner@uni-tuebingen.de.

المصدر: RMD open [RMD Open] 2024 Jul 14; Vol. 10 (3). Date of Electronic Publication: 2024 Jul 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Autoimmune Diseases*/therapy , Autoimmune Diseases*/etiology , Transplantation, Autologous*, Humans ; Female ; Male ; Adolescent ; Child ; Treatment Outcome ; Young Adult ; Follow-Up Studies